The LDN 2026 Virtual Conference Recordings
The LDN 2026 Virtual Conference Recordings is designed to provide high-quality, evidence-based continuing medical education through a comprehensive series of on-demand presentations. This virtual format allows participants to engage with educational content at a time and location that best accommodates their clinical and professional commitments. An application for Continuing Medical Education (CME) credits will be submitted. The program will feature presentations by experienced clinicians and subject-matter experts with clinical and research expertise in Low-Dose Naltrexone (LDN). Faculty: Click Here Learning Objectives Upon completion of this educational activity, participants should be able to: Explain the proposed mechanisms of action of Low-Dose Naltrexone, including its immunomodulatory and neuroinflammatory effects Assess the current evidence base for the use of LDN in selected chronic and complex medical conditions Identify appropriate patient selection criteria, dosing cons